Adam Kennedy

Adam Kennedy serves as the Associate Director at Metabolon, Inc. since March 2020, following prior roles including Director of Advanced Technology at Baebies and extensive positions at Metabolon, where significant advancements in research and development in diagnostics and precision medicine were achieved. Adam's expertise encompasses the development of blood-based diagnostic assays, management of federally funded grants, and engagement in translational research to enhance therapeutic discoveries. With a strong foundation in biochemistry and molecular genetics, evidenced by a Ph.D. from the University of Virginia, Adam has contributed to multiple successful studies, collaborations, and revenue generation throughout a diverse career in both academic and corporate research environments.